Trinity Resources Inc

PINK:TRRI USA Biotechnology
Market Cap
$90.32K
Market Cap Rank
#48725 Global
#14952 in USA
Share Price
$0.06
Change (1 day)
+0.00%
52-Week Range
$0.06 - $0.12
All Time High
$1.76
About

Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases. The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022. The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.

Trinity Resources Inc (TRRI) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of September 2023: 0.009x

Based on the latest financial reports, Trinity Resources Inc (TRRI) has a cash flow conversion efficiency ratio of 0.009x as of September 2023.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.59K) by net assets ($-386.73K). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Trinity Resources Inc - Cash Flow Conversion Efficiency Trend (2008–2022)

This chart illustrates how Trinity Resources Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Trinity Resources Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Trinity Resources Inc ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Trinity Resources Inc (2008–2022)

The table below shows the annual cash flow conversion efficiency of Trinity Resources Inc from 2008 to 2022.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2022-12-31 $-218.08K $-88.20K 0.404x +146.97%
2021-12-31 $-52.69K $45.37K -0.861x -16688.79%
2012-12-31 $-101.97K $523.00 -0.005x -101.87%
2011-12-31 $1.05 Million $286.42K 0.274x +358.04%
2010-12-31 $1.20 Million $71.97K 0.060x +115.59%
2009-12-31 $621.41K $-238.36K -0.384x -135.42%
2008-12-31 $330.01K $357.35K 1.083x --